sulfasalazine has been researched along with Rheumatism in 30 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Medication overdoses, drug-drug interactions but also chronic administration of medications at the recommended doses may lead to ocular toxicity." | 2.46 | Ocular side effects of anti-rheumatic medications: what a rheumatologist should know. ( Bonovas, S; Chalkiadakis, SE; Kyttaris, VC; Peponis, V; Sitaras, NM, 2010) |
| "Sulfasalazine has a fairly rapid onset of clinical effects and modulates immune function." | 2.38 | Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine. ( Brooks, P; Conaghan, PG, 1993) |
| "There is paucity of data on extended dosing interval between two doses of AZD1222 (AstraZeneca) in patients with Autoimmune Rheumatic Diseases (AIRD)." | 1.72 | Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease. ( Ahmed, S; Benny, J; Cherian, S; Mehta, P; Panthak, A; Paul, A; Shenoy, P, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (30.00) | 18.7374 |
| 1990's | 9 (30.00) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 2 (6.67) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, P | 1 |
| Paul, A | 1 |
| Ahmed, S | 1 |
| Cherian, S | 1 |
| Panthak, A | 1 |
| Benny, J | 1 |
| Shenoy, P | 1 |
| Larid, G | 1 |
| Brigaud, A | 1 |
| Bergeal, E | 1 |
| Gervais, E | 1 |
| RodrÃguez-Reyna, TS | 1 |
| MartÃnez-Reyes, C | 1 |
| Yamamoto-Furusho, JK | 1 |
| Peponis, V | 1 |
| Kyttaris, VC | 1 |
| Chalkiadakis, SE | 1 |
| Bonovas, S | 1 |
| Sitaras, NM | 1 |
| Miller, AV | 1 |
| Ranatunga, SK | 1 |
| Schiemann, U | 1 |
| Kellner, H | 1 |
| Klaukka, T | 1 |
| Kaarela, K | 1 |
| ZYLBERBLAT, L | 1 |
| Kumar, N | 1 |
| Kay, LJ | 1 |
| Walker, DJ | 1 |
| Ostensen, M | 1 |
| Scherer, HU | 1 |
| Burmester, GR | 1 |
| Vroom, F | 1 |
| van Roon, EN | 1 |
| van den Berg, PB | 1 |
| Brouwers, JR | 1 |
| de Jong-van den Berg, LT | 1 |
| Littler, TR | 1 |
| Axford, JS | 1 |
| Alavi, A | 1 |
| Mielke, H | 1 |
| Wildhagen, K | 1 |
| Mau, W | 1 |
| Zeidler, H | 1 |
| Conaghan, PG | 1 |
| Brooks, P | 1 |
| Dougados, M | 1 |
| Amos, RS | 1 |
| Nasonov, EL | 1 |
| Utley, M | 1 |
| Gallivan, S | 1 |
| Young, A | 1 |
| Cox, N | 1 |
| Davies, P | 1 |
| Dixey, J | 1 |
| Emery, P | 1 |
| Gough, A | 1 |
| James, D | 1 |
| Prouse, P | 1 |
| Williams, P | 1 |
| Winfield, J | 1 |
| Devlin, JA | 1 |
| Hollister, JR | 1 |
| Smith, MD | 2 |
| Porter, DR | 1 |
| Capell, HA | 1 |
| van de Putte, LB | 1 |
| van Riel, PL | 1 |
| Abadia, R | 1 |
| Jammet, P | 1 |
| Christoforov, B | 1 |
| Cremer, GA | 1 |
| O'Callaghan, JW | 1 |
| Brooks, PM | 1 |
| Golding, DN | 1 |
| Zanen, P | 1 |
| Goldman, P | 1 |
| Peppercorn, MA | 1 |
19 reviews available for sulfasalazine and Rheumatism
| Article | Year |
|---|---|
Rheumatic manifestations of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cadherins; Cytokines; Gastroenter | 2009 |
Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antimetabolites; Antirheumatic Agents; Bone | 2010 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monocl | 2012 |
[Gastrointestinal side effects in the therapy of rheumatologic diseases].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic | 2002 |
[Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding].
Topics: Abnormalities, Drug-Induced; Antirheumatic Agents; Breast Feeding; Cyclophosphamide; Drug Combinatio | 2006 |
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monocl | 2006 |
Anti-rheumatic drugs.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Dapso | 1981 |
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine.
Topics: Anti-Inflammatory Agents; Antimalarials; Drug Therapy, Combination; Gold; Humans; Methotrexate; Peni | 1993 |
Sulphasalazine in rheumatic diseases.
Topics: Humans; Rheumatic Diseases; Sulfasalazine | 1993 |
The history of the use of sulphasalazine in rheumatology.
Topics: Antirheumatic Agents; Clinical Trials as Topic; Humans; Rheumatic Diseases; Sulfasalazine | 1995 |
[Sulphasalazine: a promising drug in rheumatology].
Topics: Antirheumatic Agents; Humans; Rheumatic Diseases; Sulfasalazine | 1997 |
Medical treatment of adolescents with rheumatic disease.
Topics: Adolescent; Adolescent Medicine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; A | 1998 |
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Arthritis, Rheumatoid; Gold; Humans; Penicil | 1990 |
The use of sulphasalazine as a disease modifying antirheumatic drug.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Hematologic Diseases; Humans; Rheumatic Diseases; Sulfasala | 1990 |
[Slow-acting antirheumatic agents].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Gold; Humans; Penicillamine; Quinoli | 1989 |
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Gold; Humans; Penicillamine; Rheumatic Disea | 1989 |
[Hepatotoxicity of drugs commonly used in rheumatology].
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Dextrop | 1985 |
Disease-modifying agents and immunosuppressive drugs in the elderly.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antimalarials; Azathioprine; Cyclophosphami | 1986 |
[Sulfasalazine as an antirheumatic agent; a review of the literature].
Topics: Dose-Response Relationship, Drug; Humans; Rheumatic Diseases; Sulfasalazine | 1988 |
1 trial available for sulfasalazine and Rheumatism
| Article | Year |
|---|---|
The treatment of enthesitis in psoriatic arthritis.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Disability Evaluation; Female; Health Status; Humans; Jo | 2004 |
10 other studies available for sulfasalazine and Rheumatism
| Article | Year |
|---|---|
Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease.
Topics: Autoimmune Diseases; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines; Humans; Methotrexate; Mycophenoli | 2022 |
Paternity desire during rheumatic diseases under DMARDs: Information of patients and neonatal consequences in a French cohort of 156 patients.
Topics: Antirheumatic Agents; Humans; Infant, Newborn; Methotrexate; Paternity; Rheumatic Diseases; Sulfasal | 2023 |
Methotrexate is the leading DMARD in Finland.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Finland; Humans; Hydroxychloroquine; Insurance, Health; | 2003 |
[Treatment of primary chronic rheumatism with salazopyrine].
Topics: Arthritis; Arthritis, Rheumatoid; Drug Combinations; Glucosamine; Rheumatic Diseases; Sulfasalazine; | 1954 |
Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
Topics: Antirheumatic Agents; Azathioprine; Databases, Factual; Drug Prescriptions; Drug Therapy, Combinatio | 2008 |
Aberrant control of galactosyltransferase.
Topics: B-Lymphocytes; Galactosyltransferases; Humans; Immunoglobulin G; Rheumatic Diseases; Sulfasalazine | 1994 |
Follow-up of patients with double stranded DNA antibodies induced by sulfasalazine during the treatment of inflammatory rheumatic diseases.
Topics: Adult; Aged; Antibodies, Antinuclear; DNA; Female; Follow-Up Studies; Humans; Lupus Erythematosus, S | 1993 |
Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies.
Topics: Antirheumatic Agents; Humans; Rheumatic Diseases; Rheumatology; Sulfasalazine; Survival Analysis | 2000 |
Sulphasalazine for palindromic rheumatism.
Topics: Humans; Rheumatic Diseases; Sulfasalazine | 1988 |
Salicylazosulfapyridine in clinical practice.
Topics: Arthritis; Colitis, Ulcerative; Humans; Rheumatic Diseases; Sulfasalazine | 1973 |